
Avalo Therapeutics, Inc.
USD19.63
+0.34 (+1.76%)
CEO
Garry A. Neil
IPO Date
2015-10-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$19.45
Prev. Close
$19.29
Day Low
$19.32
Day High
$19.84
52W Low
$4.61
52W High
$24.27
Market Cap
$0.22B
Volume
0.08M
| HC Wainwright & Co. |
| Buy |
| Buy |
| maintain |
| 14 May 2026 | Citizens | Market Outperform | Market Outperform | maintain |
| 11 May 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 6 May 2026 | Citizens | Market Outperform | Market Outperform | maintain |
| 6 May 2026 | BTIG | Buy | Buy | maintain |
| 6 May 2026 | Wedbush | Outperform | Outperform | maintain |
| 13 Apr 2026 | BTIG | Buy | Buy | maintain |